阿尔凯默斯

ALKS NASDAQ
23.25
+0.42
+1.84%
交易中 12:14 07/23 EDT
开盘
22.84
昨收
22.83
最高
23.34
最低
22.84
成交量
31.33万
成交均量(3M)
133.93万
52周最高
46.98
52周最低
21.29
换手率
0.20%
市值
36.48亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供阿尔凯默斯 ALKS股票价格,阿尔凯默斯股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Alkermes plc is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of marketed drug products and a clinical pipeline of products that address central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis (MS). The Company's products include ARISTADA, VIVITROL, INVEGA SUSTENNA, XEPLION, INVEGA TRINZA, TREVICTA, RISPERDAL CONSTA, AMPYRA, FAMPYRA, BYDUREON, Aripiprazole lauroxil, ALKS 5461, ALKS 3831, ALKS 8700, ALKS 6428, ALKS 4230 and ALKS 7119. The Company's product platforms include injectable extended-release microsphere technology, LinkeRx technology, NanoCrystal technology and oral controlled release (OCR) technology. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia.
展开 >

最近浏览

名称
价格
涨跌幅